Septerna (SEPN) EBITDA (2023 - 2026)

Septerna's quarterly EBITDA came in at -$9.8 million in Q1 2026, up 53.96% year-on-year from -$6.4 million in Q1 2025, and down 123.38% quarter-over-quarter from $42.0 million in Q4 2025.

Septerna has reported EBITDA for 4 years, with the latest figure at -$9.8 million in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA rose 53.96% year-over-year to -$9.8 million; the trailing twelve-month figure through Mar 2026 stood at $15.7 million (up 118.96% YoY), and the FY2025 full-year result was -$10.3 million, up 87.3% from the prior year.
  • EBITDA for Q1 2026 stood at -$9.8 million, down from $42.0 million in the prior quarter.
  • The five-year high for EBITDA was $42.0 million in Q4 2025, with the low at -$24.9 million in Q2 2025.
  • Average EBITDA over 4 years is -$5.3 million, with a median of -$14.2 million recorded in 2024.
  • Year-over-year, EBITDA plunged 172.03% in 2024 and soared 269.97% in 2025.
  • Tracing SEPN's EBITDA over 4 years: stood at $34.3 million in 2023, then plunged by 172.03% to -$24.7 million in 2024, then soared by 269.97% to $42.0 million in 2025, then plunged by 123.38% to -$9.8 million in 2026.
  • The last three EBITDA figures came in at -$9.8 million (Q1 2026), $42.0 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.63 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.44 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.14 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 661.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 201.19 Mn
10 Septerna 1.34 Bn 1.34 Bn - -9.82 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.82 Mn
Dec 31, 2025 42.01 Mn
Sep 30, 2025 8.37 Mn
Jun 30, 2025 -24.86 Mn
Mar 31, 2025 -21.33 Mn
Dec 31, 2024 -24.72 Mn
Sep 30, 2024 -20.34 Mn
Jun 30, 2024 -16.44 Mn
Mar 31, 2024 -14.17 Mn
Dec 31, 2023 34.32 Mn
Sep 30, 2023 -10.95 Mn